Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
Exponent Inc. (Nasdaq: EXPO) is a leading engineering and scientific consulting firm dedicated to providing solutions to complex issues faced by various industries. The company operates through a highly multidisciplinary organization comprising scientists, physicians, engineers, and business consultants, bringing together over 90 technical disciplines. With a presence in 20 offices across the United States and 6 international locations, Exponent is committed to delivering unparalleled technical expertise.
Core Business and Services: Exponent operates through two main segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment, which accounts for the majority of Exponent's revenue, focuses on services such as biomechanics, biomedical engineering, civil engineering, and construction consulting. The Environmental and Health segment addresses chemical regulation, food safety, ecological and biological sciences, and environmental and earth sciences.
Latest Achievements: Exponent recently reported a 5% increase in total revenues for the third quarter of 2023, highlighting its adaptability and diversified portfolio. The company also announced a quarterly cash dividend of $0.26 per share to be paid in December 2023 and has continued its commitment to return value to shareholders through dividends and stock repurchases.
Recent Projects: The firm is actively engaged in failure analysis and dispute-related work across multiple sectors, including consumer electronics, transportation, and energy. It has also been involved in regulatory consulting services for the chemical industry and in providing safety-related evaluations.
Financial Condition: Exponent's financial results for the first three quarters of 2023 include a 7% increase in total revenues to $413.9 million. The company closed the period with $137.1 million in cash and cash equivalents, indicating robust financial health.
Partnerships and Collaborations: Exponent collaborates with a wide range of clients, including multinational corporations, startups, law firms, insurance companies, and government agencies. This diverse client base underscores the firm's ability to address a variety of complex challenges.
In summary, Exponent Inc. continues to leverage its deep technical expertise and multidisciplinary approach to address the evolving needs of modern industries, ensuring long-term growth and value creation for its stakeholders.
Exponent (NASDAQ: EXPO) reported Q3 2024 financial results with flat revenues before reimbursements at $125.1 million, while total revenues increased 2% to $136.3 million. Net income grew 6% to $26.0 million ($0.50 per diluted share), and EBITDA margin expanded by 100 basis points to 28.6%. The company saw healthy rebound in consumer electronics sector, offset by challenges in chemicals. Year-to-date results showed 3% growth in revenues before reimbursements to $394.7 million, with net income of $85.4 million ($1.66 per diluted share). The company maintained revenue guidance and raised margin guidance for full-year 2024.
Exponent (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.28 per share for Q4 2024, payable on December 20, 2024, to stockholders of record as of December 6, 2024. The company maintains its quarterly dividend schedule in March, June, September, and December, subject to Board approval. CEO Dr. Catherine Corrigan emphasized the company's commitment to shareholders, highlighting their diverse services portfolio and aligned operating model as key factors in capturing market demand and delivering long-term value.
Exponent, Inc. (Nasdaq: EXPO) has announced it will report its Third Quarter of fiscal year 2024 financial results on Thursday, October 24, 2024, after market close. The results will cover the period ended September 27, 2024. Following the release, the company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the business and financial results.
The call will be led by Dr. Catherine Corrigan, CEO and President, and Richard Schlenker, Executive VP and CFO. Investors can join the live call at (844) 481-2781 or (412) 317-0672. A live and archived webcast will be available from the Investor Relations section of Exponent's website. A telephonic replay will be accessible until October 31, 2024, by dialing (877) 344-7529 or (412) 317-0088 with passcode 1389454#.
Exponent, Inc. (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.28 per share of common stock, payable on September 20, 2024, to stockholders of record as of September 6, 2024. The company maintains its practice of paying quarterly dividends in March, June, September, and December. Dr. Catherine Corrigan, President and CEO, emphasized Exponent's commitment to shareholders through this dividend, citing strong market drivers and strategic positioning as enablers of sustainable long-term growth. Future dividend declarations remain subject to the Board of Directors' final determination.
Exponent, Inc. (Nasdaq: EXPO) reported its Q2 2024 financial results, showing flat total revenues at $140.5 million and a 2% increase in revenues before reimbursements to $132.4 million. Net income grew 14% to $29.2 million, or $0.57 per diluted share. EBITDA increased to $39.9 million, representing 30.2% of revenues before reimbursements. The company's engineering and scientific segment, accounting for 84% of revenues, grew 4% in Q2. Despite challenges in consumer electronics and chemicals sectors, Exponent saw growth in transportation, utilities, and medical device sectors. The company raised its full-year 2024 guidance, expecting low to mid-single digit growth in revenues before reimbursements and EBITDA to be 27.5% to 28.0% of revenues before reimbursements.
Exponent (Nasdaq: EXPO) will announce its financial results for the second quarter of fiscal year 2024 on July 25, 2024, after the market closes. The results cover the period ending June 28, 2024. On the same day, CEO Dr. Catherine Corrigan and CFO Richard Schlenker will host a conference call and webcast at 4:30 p.m. ET to discuss the company's business and financial performance. Interested parties can join the live call by dialing (844) 481-2781 or (412) 317-0672, and a replay will be available until August 1, 2024, by dialing (877) 344-7529 or (412) 317-0088 with passcode 2296670#. Both the live and archived webcast will be accessible via Exponent's Investor Relations webpage.
FAQ
What is the current stock price of Exponent (EXPO)?
What is the market cap of Exponent (EXPO)?
What services does Exponent Inc. offer?
What are Exponent's main business segments?
How has Exponent performed financially recently?
Where is Exponent Inc. located?
Who are Exponent's clients?
What recent projects has Exponent been involved in?
What recent achievements has Exponent announced?
What is Exponent's approach to problem-solving?
How can I contact Exponent Inc.?
What is Exponent's outlook for the future?
